JBIO
Jade Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Tom Frohlich
IPO Date
2025-04-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Jade Biosciences, Inc.
CEO
Tom Frohlich
IPO Date
2025-04-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US